Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Visit the official website of the International Institute of Anticancer Research

 

Current Issue

July-August 2025 (Vol. 39 Issue 4) Table of Contents
In Vivo: 39 (4)

Issue highlights

  • Identification of Serum Biomarkers for Blast-induced Traumatic Brain Injuries: Low vs. High-intensity Exposure in a Rat Model
  • Comprehensive Analysis of Proteinuria and Nephrotic Syndrome Using the Japanese Adverse Drug Event Reporting Database
  • Glatiramer Acetate Reduces Risk of Cardiovascular Disease and Myocardial Infarction
  • Impact of Vitamin D Receptor Genotypes on Taiwan Asthma Risk
  • Urinary Metabolites as Biomarkers of Early Radiation Cystitis in Patients With Prostate Cancer Undergoing Radiotherapy

 


 

Two Special Issues are coming in 2025:

  1. Diabetes: New Antidiabetic Agents; Stem Cell Therapy; Pancreas Transplantation  – 2025 (Submission deadline: September 30, 2025; Publication date: January 2026). ​Click here for more information. 
  2. "In Vivo, In Vitro and In Silico Characterization of Permanent and Biodegradable Implants" is now published and you may find it here.

Featured Articles

  • Coronavirus Disease (COVID-19): A Machine Learning Bibliometric Analysis
    June 05, 2020
  • Curcumin Suppression of Cytokine Release and Cytokine Storm. A Potential Therapy for Patients with...
    January 19, 2015
  • Anti-inflammatory Activity of β-Carotene, Lycopene and Tri-n-butylborane, a Scavenger of...
    February 23, 2018
  • Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving...
    April 25, 2018
  • Breast Cancer and COVID-19: The Effect of Fear on Patients' Decision-making Process
    June 05, 2020

Latest Articles

  • Open Access
    A Case of Seronegative Lupus Nephritis Detected Incidentally by Renal Biopsy
    AKIRA MIMA, TAKAMASA MATSUKI, TAKAHIRO NAKAMOTO, YUTA SAITO, TAKAAKI MORIKAWA, SAKURA KURE, KEISHI MATSUMOTO and SHINJI LEE
    In Vivo July 2025, 39 (4) 2328-2332; DOI: https://doi.org/10.21873/invivo.14029
  • Open Access
    Ifosfamide, Carboplatin, and Etoposide as Neoadjuvant Chemotherapy in Patients With Neurofibromatosis Type I-related Malignant Peripheral Nerve Sheath Tumors
    JUNJI WASA, HIROHISA KATAGIRI, HIDEKI MURATA, SHUNICHI TOKI, KAN ITO and MITSURU TAKAHASHI
    In Vivo July 2025, 39 (4) 2267-2276; DOI: https://doi.org/10.21873/invivo.14022
  • Open Access
    Effect of Pembrolizumab on Lymph Node Dissection in Patients Who Experienced Bladder Cancer Recurrence Following Radical Cystectomy
    YOSHIHIKO TASAKI, TAKASHI NAGAI, TAKU NAIKI, YUSUKE NODA, RYOSEI OKAWA, MISATO TOMITA, YOSUKE SUGIYAMA, YOSHIHISA MIMURA, KUNIHIRO ODAGIRI, NANAMI ITO, YUJI HOTTA, NOBUHIKO SHIMIZU, TOSHIKI ETANI, SHUZO HAMAMOTO, ATSUSHI OKADA, YOKO FURUKAWA-HIBI and TAKAHIRO YASUI
    In Vivo July 2025, 39 (4) 2196-2208; DOI: https://doi.org/10.21873/invivo.14015
  • Open Access
    Risk Factors Associated With Thrombocytopenia Induced by Intravenous Immunoglobulin Formulations: An Analysis Using the JADER database
    YOSHIHIRO NISHITA, NATSUKO ISHIDA, HIROFUMI NAGAI, TOGEN MASAUJI and JUNKO ISHIZAKI
    In Vivo July 2025, 39 (4) 2320-2327; DOI: https://doi.org/10.21873/invivo.14028
  • Open Access
    NeuroD2 Modulates Hippocampal Neuronal Organization and Axon Guidance During Aging
    MERVE BEKER, BUSENUR BOLAT, BAHAR SARIKAMIS JOHNSON, NILUFER ERCIN, RABIA KALKAN CAKMAK, SARE B. KAYA, NAIL BESLI, ULKAN CELIK and MUSTAFA C. BEKER
    In Vivo July 2025, 39 (4) 2050-2065; DOI: https://doi.org/10.21873/invivo.14000
  • Open Access
    Impact of Adjuvant Chemotherapy Following Neoadjuvant Concurrent Chemoradiotherapy and Total Mesorectal Excision in Rectal Cancer
    YU-SHIH LIU, JEN-KOU LIN, TZU-CHEN LIN, WEI-SHONE CHEN, SHUNG-HAUR YANG, HUANN-SHENN WANG, SHIH-CHING CHANG, YUAN-TZU LAN, CHUN-CHI LIN, HUNG-HSIN LIN and JENG-KAI JIANG
    In Vivo July 2025, 39 (4) 2311-2319; DOI: https://doi.org/10.21873/invivo.14027
View more latest articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
γ-H2AX - A Novel Biomarker for DNA Double-strand Breaks
The Antitumor Activities of Flavonoids
Melanoma: Epidemiology, Risk Factors, Pathogenesis, Diagnosis and Classification
Muscle Regeneration: Cellular and Molecular Events
Radioprotection
Intraarterial Hepatic Chemoembolization of Liver Metastases from Colorectal Cancer Adopting Irinotecan-eluting Beads: Results of a Phase II Clinical Study
Visit the official website of In Vivo.
 
Back to top
In Vivo

© 2025 In Vivo

Powered by HighWire